Status: Recruiting
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors
This is a study of ATG-037 Monotherapy and Combination Therapy with Pembrolizumab in Patients with Locally Advanced or Metastatic Solid Tumors
Participants needed: 98
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Antengene Therapeutics LimitedUpdated: Jun 9, 2025Locations: 7
Eligibility criteria
Provision of signed and dated, written informed consent prior to any study-speci... [+9]
Primary central nervous system disease, central nervous system metastatic diseas... [+9]